BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1200 related articles for article (PubMed ID: 19331862)

  • 1. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
    Rekha MR; Sharma CP
    J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and in-vivo evaluation of insulin-loaded chitosan phthalate microspheres for oral delivery.
    Ubaidulla U; Khar RK; Ahmed FJ; Panda AK
    J Pharm Pharmacol; 2007 Oct; 59(10):1345-51. PubMed ID: 17910808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alginate/chitosan nanoparticles are effective for oral insulin delivery.
    Sarmento B; Ribeiro A; Veiga F; Sampaio P; Neufeld R; Ferreira D
    Pharm Res; 2007 Dec; 24(12):2198-206. PubMed ID: 17577641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery.
    Makhlof A; Tozuka Y; Takeuchi H
    Eur J Pharm Sci; 2011 Apr; 42(5):445-51. PubMed ID: 21182939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral bioavailability of insulin contained in polysaccharide nanoparticles.
    Sarmento B; Ribeiro A; Veiga F; Ferreira D; Neufeld R
    Biomacromolecules; 2007 Oct; 8(10):3054-60. PubMed ID: 17877397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation, characterization, and oral delivery of insulin loaded carboxylated chitosan grafted poly(methyl methacrylate) nanoparticles.
    Cui F; Qian F; Zhao Z; Yin L; Tang C; Yin C
    Biomacromolecules; 2009 May; 10(5):1253-8. PubMed ID: 19292439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclodextrin complexed insulin encapsulated hydrogel microparticles: An oral delivery system for insulin.
    Sajeesh S; Bouchemal K; Marsaud V; Vauthier C; Sharma CP
    J Control Release; 2010 Nov; 147(3):377-84. PubMed ID: 20727924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery.
    Lin YH; Mi FL; Chen CT; Chang WC; Peng SF; Liang HF; Sung HW
    Biomacromolecules; 2007 Jan; 8(1):146-52. PubMed ID: 17206800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanoparticles of quaternized chitosan derivatives as a carrier for colon delivery of insulin: ex vivo and in vivo studies.
    Bayat A; Dorkoosh FA; Dehpour AR; Moezi L; Larijani B; Junginger HE; Rafiee-Tehrani M
    Int J Pharm; 2008 May; 356(1-2):259-66. PubMed ID: 18289808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged antidiabetic effect of zinc-crystallized insulin loaded glycol chitosan nanoparticles in type 1 diabetic rats.
    Jo HG; Min KH; Nam TH; Na SJ; Park JH; Jeong SY
    Arch Pharm Res; 2008 Jul; 31(7):918-23. PubMed ID: 18704336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and development of gliclazide-loaded chitosan for oral sustained drug delivery: in vitro/in vivo evaluation.
    Barakat NS; Almurshedi AS
    J Microencapsul; 2011; 28(2):122-33. PubMed ID: 21110773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thiol functionalized polymethacrylic acid-based hydrogel microparticles for oral insulin delivery.
    Sajeesh S; Vauthier C; Gueutin C; Ponchel G; Sharma CP
    Acta Biomater; 2010 Aug; 6(8):3072-80. PubMed ID: 20144748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucoadhesive hydrogel microparticles based on poly (methacrylic acid-vinyl pyrrolidone)-chitosan for oral drug delivery.
    Sajeesh S; Sharma CP
    Drug Deliv; 2011 May; 18(4):227-35. PubMed ID: 21067275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
    Zhang Y; Wei W; Lv P; Wang L; Ma G
    Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: Oral delivery using pH-responsive nanoparticles vs. subcutaneous injection.
    Sonaje K; Lin KJ; Wey SP; Lin CK; Yeh TH; Nguyen HN; Hsu CW; Yen TC; Juang JH; Sung HW
    Biomaterials; 2010 Sep; 31(26):6849-58. PubMed ID: 20619787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal mucosa permeability following oral insulin delivery using core shell corona nanolipoparticles.
    Li X; Guo S; Zhu C; Zhu Q; Gan Y; Rantanen J; Rahbek UL; Hovgaard L; Yang M
    Biomaterials; 2013 Dec; 34(37):9678-87. PubMed ID: 24016855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs.
    Lin YH; Sonaje K; Lin KM; Juang JH; Mi FL; Yang HW; Sung HW
    J Control Release; 2008 Dec; 132(2):141-9. PubMed ID: 18817821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous Effect of Thiolation and Carboxylation of Chitosan Particles Towards Mucoadhesive Oral Insulin Delivery Applications: An In Vitro and In Vivo Evaluation.
    Rekha MR; Sharma CP
    J Biomed Nanotechnol; 2015 Jan; 11(1):165-76. PubMed ID: 26301311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Goblet cell-targeting nanoparticles for oral insulin delivery and the influence of mucus on insulin transport.
    Jin Y; Song Y; Zhu X; Zhou D; Chen C; Zhang Z; Huang Y
    Biomaterials; 2012 Feb; 33(5):1573-82. PubMed ID: 22093292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery.
    Sajeesh S; Sharma CP
    Int J Pharm; 2006 Nov; 325(1-2):147-54. PubMed ID: 16859846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.